Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AKBA Akebia Therapeutics, Inc.

盘后交易 11-22 19:53:09 EST

1.88

+0.06

+3.30%

盘后1.90

+0.02+1.06%

19:40 EST

最高1.90	最低1.81	成交量201.12万
今开1.84	昨收1.82	日振幅5.19%
总市值4.10亿	流通市值3.73亿	总股本2.18亿
成交额373.86万	换手率1.01%	流通股本1.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AKBA","market":"US","secType":"STK","nameCN":"Akebia Therapeutics, Inc.","latestPrice":1.88,"timestamp":1732309200000,"preClose":1.82,"halted":0,"volume":2011212,"hourTrading":{"tag":"盘后","latestPrice":1.9,"preClose":1.88,"latestTime":"19:40 EST","volume":18633,"amount":35144.6124537,"timestamp":1732322410330},"delay":0,"floatShares":198273825,"shares":218181202,"eps":-0.228513,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.06,"latestTime":"11-22 19:53:09 EST","open":1.84,"high":1.8995,"low":1.805,"amount":3738643.5957696,"amplitude":0.051923,"askPrice":1.9,"askSize":200,"bidPrice":1.86,"bidSize":268,"shortable":3,"etf":0,"ttmEps":-0.228513,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1395288000000,"adjPreClose":1.82,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.82,"latestTime":"09:29 EST","volume":15140,"amount":27635.356912000003,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":1.9,"preClose":1.88,"latestTime":"19:40 EST","volume":18633,"amount":35144.6124537,"timestamp":1732322410330},"volumeRatio":1.316566,"impliedVol":0.834,"impliedVolPercentile":0.2937},"requestUrl":"/m/hq/s/AKBA/tweets","defaultTab":"tweets","newsList":[{"id":"2484548998","title":"Akebia Therapeutics, Inc.2024财年第三财季实现净利润-20.04百万美元，同比减少38.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548998?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772998,"startTime":"0","endTime":"0","summary":"11月17日，Akebia Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.04百万美元，同比减少38.30%；其中营业收入为37.43百万美元，同比减少10.99%，每股基本收益为-0.10美元。机构评级：截至2024年11月17日，当前有3家机构对Akebia Therapeutics, Inc.目标价做出预测，其中目标均价为5.50美元，其中最低目标价为4.00美元，最高目标价为7.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423a23e070a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423a23e070a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","LENZ"],"gpt_icon":0},{"id":"2483505838","title":"Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.28%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483505838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483505838?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:39","pubTimestamp":1731436767,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时39分，Akebia Therapeutics, Inc.股票出现波动，股价急速下挫5.28%。截至发稿，该股报1.89美元/股，成交量127.083万股，换手率0.60%，振幅5.28%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.10%。其相关个股中，Biofrontera Inc.、Biofrontera Inc C/Wts 27/10/2026 、Cronos Group Inc. Common Share涨幅较大，Rockwell Medical, Inc.、Sonoma Pharmaceuticals, Inc.、Canopy Growth Corporation较为活跃，换手率分别为15.92%、12.82%、10.65%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Biofrontera Inc.、Sunshine Biopharma Inc C/Wts ，振幅分别为32.37%、25.60%、24.14%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113023927971a6193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113023927971a6193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"gpt_icon":0},{"id":"2481186701","title":"Akebia Therapeutics, Inc.股价重挫14.97% 市值跌5353.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481186701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481186701?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:32","pubTimestamp":1730989961,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时32分，Akebia Therapeutics, Inc.股票出现异动，股价快速下跌14.97%。截至发稿，该股报1.70美元/股，成交量95.3561万股，换手率0.45%，振幅4.50%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.71%。其相关个股中，Emergent Biosolutions Inc.、Evotec Se、Mira Pharmaceuticals, Inc.涨幅较大，Sunshine Biopharma Inc.、Esperion Therapeutics, Inc.、坎伯兰药业较为活跃，换手率分别为1.91%、0.92%、0.92%，振幅较大的相关个股有Ironwood医药、Esperion Therapeutics, Inc.、坎伯兰药业，振幅分别为11.51%、9.95%、4.57%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722324295bde669&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722324295bde669&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ"],"gpt_icon":0},{"id":"2480580948","title":"Akebia Therapeutics Inc    预计每股亏损 6 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580948","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580948?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:41","pubTimestamp":1730734880,"startTime":"0","endTime":"0","summary":"   * Akebia Therapeutics Inc    预计将在11月7日公布截至2024年9月30日的季度收入报告。* LSEG 分析师对 Akebia Therapeutics Inc 的平均预期是每股亏损 6 美分。* 华尔街对 Akebia Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元，高于其上一次收盘价 1.69 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","AKBA"],"gpt_icon":0},{"id":"2480827587","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480827587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480827587?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:18","pubTimestamp":1730733502,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时18分，Akebia Therapeutics, Inc.股票出现异动，股价大幅拉升5.03%。截至发稿，该股报1.78美元/股，成交量66.5747万股，换手率0.32%，振幅4.14%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.40%。其相关个股中，Evotec Se、Canopy Growth Corporation、Flora Growth Corp.涨幅较大，Biofrontera Inc.、Canopy Growth Corporation、Mira Pharmaceuticals, Inc.较为活跃，换手率分别为9.79%、4.66%、4.51%，振幅较大的相关个股有Journey Medical Corporation、Mira Pharmaceuticals, Inc.、脑再生科技，振幅分别为21.64%、15.26%、12.61%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104231822971a4311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104231822971a4311&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"gpt_icon":0},{"id":"2480882399","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480882399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480882399?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:16","pubTimestamp":1730470601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时16分，Akebia Therapeutics, Inc.股票出现异动，股价快速上涨5.12%。截至发稿，该股报1.75美元/股，成交量51.495万股，换手率0.24%，振幅3.58%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.06%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Alvotech C/Wts 、Canopy Growth Corporation涨幅较大，Biofrontera Inc.、Evoke Pharma, Inc.、Mira Pharmaceuticals, Inc.较为活跃，换手率分别为31.21%、4.85%、4.74%，振幅较大的相关个股有Biofrontera Inc.、脑再生科技、Flora Growth Corp.，振幅分别为13.82%、10.73%、9.75%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101221641a2098397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101221641a2098397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2479094239","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479094239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479094239?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:46","pubTimestamp":1730220370,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时46分，Akebia Therapeutics, Inc.股票出现波动，股价急速上涨5.52%。截至发稿，该股报1.72美元/股，成交量138.255万股，换手率0.66%，振幅6.13%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.02%。其相关个股中，Shuttle Pharmaceuticals Holdings, Inc.、Mira Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Evoke Pharma, Inc.、Mira Pharmaceuticals, Inc.较为活跃，换手率分别为1730.82%、50.73%、20.72%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Shuttle Pharmaceuticals Holdings, Inc.、Alvotech C/Wts ，振幅分别为49.35%、45.86%、30.99%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030004610ab7f98b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030004610ab7f98b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"gpt_icon":0},{"id":"2477357559","title":"Akebia Therapeutics, Inc.盘中异动 快速跳水5.18%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477357559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477357559?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:52","pubTimestamp":1729702374,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时52分，Akebia Therapeutics, Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报1.56美元/股，成交量176.16万股，换手率0.84%，振幅8.23%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.84%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.、Alvotech C/Wts 涨幅较大，Quantum Biopharma Ltd.、Painreform Ltd.、Canopy Growth Corporation较为活跃，换手率分别为16.94%、15.36%、8.55%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.、Citius Oncology, Inc.，振幅分别为71.74%、19.44%、13.74%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400525598e3e0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400525598e3e0b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"gpt_icon":0},{"id":"2477309613","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477309613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477309613?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:54","pubTimestamp":1729605263,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时54分，Akebia Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。截至发稿，该股报1.44美元/股，成交量45.7192万股，换手率0.22%，振幅3.58%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.09%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Painreform Ltd.、Shuttle Pharmaceuticals Holdings, Inc.涨幅较大，Painreform Ltd.、Sonoma Pharmaceuticals, Inc.、Akanda Corp.较为活跃，换手率分别为41.98%、19.01%、4.47%，振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Painreform Ltd.，振幅分别为11.78%、11.63%、10.35%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022215423ab6c3f1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022215423ab6c3f1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"gpt_icon":0},{"id":"2473103606","title":"Akebia Therapeutics, Inc.盘中异动 早盘急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473103606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473103606?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:31","pubTimestamp":1728307868,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分，Akebia Therapeutics, Inc.股票出现波动，股价急速上涨5.26%。截至发稿，该股报1.40美元/股，成交量5.4683万股，换手率0.03%，振幅0.00%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.16%。其相关个股中，脑再生科技、Biofrontera Inc.、Alvotech C/Wts 涨幅较大，Biofrontera Inc.、Quantum Biopharma Ltd.、苏轩堂较为活跃，换手率分别为25.78%、1.05%、0.68%，振幅较大的相关个股有Organogenesis Holdings Inc.、Assertio Holdings, Inc.、Shuttle Pharmaceuticals Holdings, Inc.，振幅分别为1.95%、1.75%、0.86%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131089719e9f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072131089719e9f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2472302231","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472302231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472302231?lang=zh_cn&edition=full","pubTime":"2024-10-02 01:15","pubTimestamp":1727802907,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日01时15分，Akebia Therapeutics, Inc.股票出现波动，股价大幅下挫5.27%。截至发稿，该股报1.25美元/股，成交量98.7279万股，换手率0.47%，振幅4.48%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.67%。其相关个股中，Flora Growth Corp.、Alvotech C/Wts 、Amneal Pharmaceuticals, Inc.涨幅较大，Guardion Health Sciences, Inc.、Canopy Growth Corporation、苏轩堂较为活跃，换手率分别为44.96%、7.88%、7.38%，振幅较大的相关个股有大自然药业、Flora Growth Corp.、脑再生科技，振幅分别为17.91%、16.34%、16.28%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020115079719dc11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020115079719dc11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2469432031","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469432031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469432031?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:33","pubTimestamp":1727102022,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时33分，Akebia Therapeutics, Inc.股票出现异动，股价快速跳水5.11%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.39%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc.涨幅较大，Painreform Ltd.、Sunshine Biopharma Inc.、Sonoma Pharmaceuticals, Inc.较为活跃，换手率分别为21.02%、12.52%、4.96%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Biofrontera Inc C/Wts 27/10/2026 、Citius Oncology, Inc.，振幅分别为59.80%、29.37%、18.75%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923223343ab655ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923223343ab655ee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"gpt_icon":0},{"id":"2460736480","title":"Akebia Therapeutics, Inc.2024财年第二财季实现净利润-8.58百万美元，同比增加23.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736480","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736480?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910649,"startTime":"0","endTime":"0","summary":"8月18日，Akebia Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-8.58百万美元，同比增加23.19%；其中营业收入为43.65百万美元，同比减少22.58%，每股基本收益为-0.04美元。从资产负债表来看，Akebia Therapeutics, Inc.总负债2.54亿美元，其中短期债务7.19百万美元，资产负债比为0.87，流动比率为1.05。机构评级：截至2024年8月18日，当前有3家机构对Akebia Therapeutics, Inc.目标价做出预测，其中目标均价为5.50美元，其中最低目标价为4.00美元，最高目标价为7.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800063095a167ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800063095a167ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","LENZ"],"gpt_icon":0},{"id":"2459789471","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459789471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459789471?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:17","pubTimestamp":1723735077,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时17分，Akebia Therapeutics, Inc.股票出现波动，股价快速上涨5.19%。截至发稿，该股报1.42美元/股，成交量68.5292万股，换手率0.33%，振幅5.93%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.07%。其相关个股中，Rockwell Medical, Inc.、Aquestive Therapeutics, Inc.、Emergent Biosolutions, Inc.涨幅较大，Siga Technologies Inc.、Sunshine Biopharma Inc.、Emergent Biosolutions, Inc.较为活跃，换手率分别为11.46%、9.83%、3.47%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Emergent Biosolutions, Inc.、Citius Oncology, Inc.，振幅分别为42.93%、19.35%、17.81%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231757ab5ddc27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231757ab5ddc27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"gpt_icon":0},{"id":"2459901831","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.28%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459901831","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459901831?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:44","pubTimestamp":1723556676,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时44分，Akebia Therapeutics, Inc.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报1.30美元/股，成交量18.9987万股，换手率0.09%，振幅4.88%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为1.48%。其相关个股中，Organigram Holdings Inc.、Evoke Pharma, Inc.、Evotec Se涨幅较大，Fsd Pharma Inc.、苏轩堂、Sunshine Biopharma Inc.较为活跃，换手率分别为25.01%、1.02%、0.97%，振幅较大的相关个股有Fsd Pharma Inc.、Organigram Holdings Inc.、Pacira Biosciences, Inc.，振幅分别为13.63%、13.21%、10.46%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321443696826042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321443696826042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"gpt_icon":0},{"id":"2458863869","title":"Akebia Therapeutics, Inc.盘中异动 急速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458863869","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458863869?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469463,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Akebia Therapeutics, Inc.股票出现波动，股价快速拉升5.86%。截至发稿，该股报1.18美元/股，成交量13.4257万股，换手率0.06%，振幅0.90%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.74%。其相关个股中，Biofrontera Inc.、脑再生科技、Akebia Therapeutics, Inc.涨幅较大，Fsd Pharma Inc.、Mira Pharmaceuticals, Inc.、脑再生科技较为活跃，换手率分别为116.71%、18.14%、1.81%，振幅较大的相关个股有Tilray Brands, Inc.、脑再生科技、Mira Pharmaceuticals, Inc.，振幅分别为17.88%、5.78%、4.76%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131039f248f46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131039f248f46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"gpt_icon":0},{"id":"2458651547","title":"Akebia Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458651547","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458651547?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:57","pubTimestamp":1723219026,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日23时57分，Akebia Therapeutics, Inc.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报1.13美元/股，成交量56.7006万股，换手率0.27%，振幅8.04%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为3.01%。其相关个股中，Fsd Pharma Inc.、Sunshine Biopharma Inc C/Wts 、Alvotech C/Wts 涨幅较大，Fsd Pharma Inc.、Sunshine Biopharma Inc.、Biofrontera Inc.较为活跃，换手率分别为1681.53%、9.11%、6.61%，振幅较大的相关个股有Fsd Pharma Inc.、Sunshine Biopharma Inc.、Sonoma Pharmaceuticals, Inc.，振幅分别为230.91%、30.62%、27.41%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809235706a1d42b5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809235706a1d42b5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ"],"gpt_icon":0},{"id":"2457169943","title":"Akebia Therapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457169943","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457169943?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:32","pubTimestamp":1723123970,"startTime":"0","endTime":"0","summary":"   * Akebia Therapeutics Inc   报告了截至6月底的季度调整后每股亏损4美分，高于去年同期的每股-6美分。* 营收同比下降 22.6%，至 4365 万美元；分析师预期为 4945 万美元。* Akebia Therapeutics Inc公布的本季度每股收益为亏损4美分。* 该公司当季亏损 858 万美元。* Akebia Therapeutics Inc 本季度股价上涨了 8.8%，今年迄今为止亏损了 10.5%。8月8日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 5.9%。华尔街对 Akebia Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2457269088","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457269088","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457269088?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:40","pubTimestamp":1723045235,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时40分，Akebia Therapeutics, Inc.股票出现异动，股价快速跳水5.69%。截至发稿，该股报1.16美元/股，成交量61.0168万股，换手率0.29%，振幅5.69%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.75%。其相关个股中，Petiq, Inc.、Supernus Pharmaceuticals, Inc.、Shuttle Pharmaceuticals Holdings, Inc.涨幅较大，Petiq, Inc.、苏轩堂、Painreform Ltd.较为活跃，换手率分别为31.33%、21.54%、15.32%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Painreform Ltd.、脑再生科技，振幅分别为35.48%、35.19%、34.07%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807234035941ff142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807234035941ff142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"gpt_icon":0},{"id":"2457338023","title":"Akebia Therapeutics, Inc.盘中异动 早盘快速上涨5.49%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457338023","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457338023?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:30","pubTimestamp":1722951023,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时30分，Akebia Therapeutics, Inc.股票出现波动，股价急速上涨5.49%。截至发稿，该股报1.25美元/股，成交量7.7661万股，换手率0.04%，振幅0.00%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，苏轩堂、Therapeuticsmd, Inc.、极光大麻涨幅较大，苏轩堂、Akanda Corp.、Redhill Biopharma Ltd较为活跃，换手率分别为3.44%、1.97%、1.41%，振幅较大的相关个股有Esperion Therapeutics, Inc.、Organon & Co.、德纳维制药，振幅分别为2.89%、1.48%、1.29%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213023aefd8556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213023aefd8556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akebia.com","stockEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.1895},{"period":"6month","weight":0.6545},{"period":"1year","weight":0.8384},{"period":"ytd","weight":0.4677}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Akebia Therapeutics, Inc.依法于2007年2月27日在特拉华州成立。该公司是一家致力于：基于缺氧诱导因子的新型生物性专有疗法的研发，肾脏疾病患者所需产品商业化应用的生物制药公司。HIF是人体内红细胞生成和潜在贫血治疗新机制的主要调节器。Akebia的候选主导产品AKB-6548作为一种每日一次的口服产品，已经成功完成2a期概念验证。研究表明AKB-6548可以在不需要透析的情况下安全有效地提高继发性贫血和慢性肾病患者的血红蛋白水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.003024},{"month":2,"riseRate":0.5,"avgChangeRate":0.084528},{"month":3,"riseRate":0.4,"avgChangeRate":-0.086789},{"month":4,"riseRate":0.454545,"avgChangeRate":0.001273},{"month":5,"riseRate":0.545455,"avgChangeRate":0.02294},{"month":6,"riseRate":0.636364,"avgChangeRate":0.041832},{"month":7,"riseRate":0.454545,"avgChangeRate":0.043821},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.024826},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.050514},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.111106},{"month":11,"riseRate":0.727273,"avgChangeRate":0.154673},{"month":12,"riseRate":0.5,"avgChangeRate":0.100433}],"exchange":"NASDAQ","name":"Akebia Therapeutics, Inc.","nameEN":"Akebia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Akebia Therapeutics, Inc.,AKBA,Akebia Therapeutics, Inc.股票,Akebia Therapeutics, Inc.股票老虎,Akebia Therapeutics, Inc.股票老虎国际,Akebia Therapeutics, Inc.行情,Akebia Therapeutics, Inc.股票行情,Akebia Therapeutics, Inc.股价,Akebia Therapeutics, Inc.股市,Akebia Therapeutics, Inc.股票价格,Akebia Therapeutics, Inc.股票交易,Akebia Therapeutics, Inc.股票购买,Akebia Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}